{
"NDC": {
"NDCCode": "72205-071-79",
"PackageDescription": "340 mL in 1 BOTTLE (72205-071-79) ",
"NDC11Code": "72205-0071-79",
"ProductNDC": "72205-071",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Perampanel",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Perampanel",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20250711",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218152",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "PERAMPANEL",
"StrengthNumber": ".5",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]",
"DEASchedule": "CIII",
"Status": "Active",
"LastUpdate": "2025-12-23",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20251215",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}